Albemarle Corporation
ALB
Classifica tra le azioni
#1878
Albemarle Corporation stands as a global innovator, producing and distributing... Albemarle Corporation stands as a global innovator, producing and distributing a diverse portfolio of engineered specialty chemicals. Its business operations are divided into three principal segments: Lithium, Bromine, and Catalysts. The Lithium division supplies a variety of lithium compounds, including lithium carbonate, hydroxide, and chloride, alongside critical reagents like butyllithium. These materials are vital for manufacturing lithium-ion batteries found in electric vehicles and consumer electronics, as well as for high-performance greases, thermoplastic elastomers used in tires and plastics, and as catalysts for chemical reactions, organic synthesis in areas like steroid chemistry, vitamins, and the pharmaceutical industry. This segment also delivers cesium products for chemical and pharmaceutical applications, zirconium, barium, and titanium for pyrotechnic devices such as airbag initiators, offers expert technical services for the safe handling of reactive lithium products, and provides recycling solutions for lithium-containing by-products. The Bromine segment focuses on bromine and bromine-based fire safety compounds. It produces an array of specialty chemicals, including elemental bromine, various bromides, and brominated powdered activated carbon, which are utilized in chemical synthesis, fluids for oil and gas drilling, mercury emission control, water purification, and food processing. Additionally, it provides tertiary amines, which serve as key ingredients in surfactants, biocides, and sanitizers. Finally, the Catalysts segment offers a range of catalytic agents, including those for hydroprocessing, isomerization, and alkylation, alongside fluidized catalytic cracking (FCC) catalysts and additives, as well as organometallics and curatives. Albemarle's products are integral to numerous industries, including energy storage, petroleum refining, consumer electronics, construction, automotive, lubricants, pharmaceuticals, and crop protection. Established in 1887, the company's headquarters are located in Charlotte, North Carolina.
Prezzo delle azioni
$95.75
Ultima sincronizzazione: 2026-10-20
Capitalizzazione di mercato
$11.30B
Variazione (1 giorno)
1.22%
Variazione (1 anno)
4.83%
Paese
US
Scambia Albemarle Corporation (ALB)
Categoria
Basic Materials
Ricavi di Albemarle Corporation (ALB)
Ricavi nel Jun 2026 TTM: $5.91B
Secondo gli ultimi rapporti finanziari di Albemarle Corporation, i ricavi attuali dell'azienda (TTM) sono pari a $5.91B. Nel 2024, l'azienda ha registrato ricavi di $5.38B una diminuzione rispetto a i ricavi dell'anno 2023, che erano pari a $9.62B. I ricavi rappresentano l'importo totale generato dalla vendita di beni o servizi. A differenza degli utili, le spese non vengono detratte.
Storico dei ricavi per Albemarle Corporation da 2000 a 2026
Ricavi alla fine di ogni anno
| Anno | Ricavi | Cambia |
|---|---|---|
| 2026 (TTM) | $5.91B | 0.00% |
| 2025 | 0.00 | -100.00% |
| 2024 | $5.38B | -44.08% |
| 2023 | $9.62B | 31.38% |
| 2022 | $7.32B | 119.96% |
| 2021 | $3.33B | 6.36% |
| 2020 | $3.13B | -12.83% |
| 2019 | $3.59B | 6.35% |
| 2018 | $3.37B | 9.86% |
| 2017 | $3.07B | 14.75% |
| 2016 | $2.68B | -26.68% |
| 2015 | $3.65B | 49.31% |
| 2014 | $2.45B | -6.53% |
| 2013 | $2.62B | -4.70% |
| 2012 | $2.75B | -4.31% |
| 2011 | $2.87B | 21.43% |
| 2010 | $2.36B | 17.82% |
| 2009 | $2.01B | -18.72% |
| 2008 | $2.47B | 5.60% |
| 2007 | $2.34B | -1.36% |
| 2006 | $2.37B | 12.38% |
| 2005 | $2.11B | 39.22% |
| 2004 | $1.51B | 36.34% |
| 2003 | $1.11B | 13.26% |
| 2002 | $980.22M | 6.91% |
| 2001 | $916.90M | -0.07% |
| 2000 | $917.55M | 0.00% |
Ricavi di aziende simili o concorrenti
| Azienda | Ricavi | Differenza nei ricavi | Il paese |
|---|---|---|---|
| $35.45B | 500.03% |
GB
|
|
| - | - |
FR
|
|
| $24.41B | 313.18% |
US
|
|
| $16.84B | 185.08% |
US
|
|
| $12.60B | 113.31% |
US
|
